Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CYTK compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name
CYTK
Cytokinetics Inc
Change
Mkt cap
Revenue
Revenue
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
CYTK
Cytokinetics Inc
vs
ASND
Ascendis Pharma A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CYTK, solid
ASND, dashed
Supply-chain overlap
Revenue flow
CYTK: latest quarter is a loss; flow not drawable. ASND: latest quarter not drawable.
Method
›
CYTK
Cytokinetics Inc
Change
62.99
▼
−0.51%
· post 63.15
Mkt cap
$8.8B
Revenue
$29M
Q2 FY26
Revenue
$88M
FY25
ASND
Ascendis Pharma A/S
Change
252.96
▼
−0.02%
· post 251.31
Closed
Oct 30 '26
Mkt cap
$15.6B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
CYTK
Cytokinetics Inc
vs
ASND
Ascendis Pharma A/S
62.99
▼
−0.51%
post 63.15
Price
252.96
▼
−0.02%
post 251.31
$8.8B
Mkt cap
$15.6B
Q2 FY26
$29M
Revenue
—
FY25
$88M
Revenue
—
Change
Change
CYTK
62.99
▼
−0.51%
vs
ASND
252.96
▼
−0.02%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CYTK
6
AMGN
Amgen
customer
KRC
Kilroy Realty
supplier
SNY
Sanofi
customer
—
Royalty Pharma Investments 2019 ICAV
unlisted
supplier
2 more · CYTK chain
›
Shared
0
No shared counterparties.
Only ASND
3
NVO
Novo Nordisk A/S
customer
—
Teijin
unlisted
customer
—
VISEN Pharmaceuticals
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR